Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

Dana, B W; Dahlberg, S; Nathwani, B N; Chase, E; Coltman, C; Miller, T P; Fisher, R I

Dana, B W; Dahlberg, S; Nathwani, B N; Chase, E; Coltman, C; Miller, T P; Fisher, R I.

Affiliation

Dana BW; Oregon Health Sciences University, Portland.

J Clin Oncol ; 11(4): 644-51, 1993 Apr.

Article in En | MEDLINE | ID: mdl-8478660

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Doxorubicin/administration & dosage; Lymphoma, Non-Hodgkin/therapy; Adult; BCG Vaccine/therapeutic use; Cyclophosphamide/administration & dosage; Female; Humans; Immunotherapy; Levamisole/therapeutic use; Lymphoma, Non-Hodgkin/drug therapy; Lymphoma, Non-Hodgkin/mortality; Male; Middle Aged; Prednisone/administration & dosage; Survival Rate; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1993 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links